What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.68%
Annual Rate
NOK 0.80Paid unknown
Payout Ratio
20.4%Sustainable
Last Ex-Dividend
May 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.51BNOK
468.38M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
29.49x
vs Conglomerates peers
Updated Oct 25, 2026
Revenue (TTM)
7.65BNOK
793.84M · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
2.63%
vs Conglomerates peers
Updated Oct 25, 2026
Beta
0.3410x
vs all stocks
Updated Oct 25, 2026
52-Week Change
34.72%
vs all stocks
Updated Oct 25, 2026
Forward Annual Dividend Yield
0.68%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
4.51BNOK
468.38M · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
6.97BNOK
723.31M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
29.49x
vs Conglomerates peers
Updated Oct 25, 2026
Forward P/E
16.60x
vs Conglomerates peers
Updated Oct 25, 2026
PEG Ratio
0.6043x
vs Conglomerates peers
Updated Oct 25, 2026
Price to Sales (TTM)
0.7790x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.59×.Updated Oct 25, 2026
Price to Book (MRQ)
2.44x
vs Conglomerates peers
Updated Oct 25, 2026
Enterprise to Revenue
0.9110x
vs Conglomerates peers
Updated Oct 25, 2026
Enterprise to EBITDA
11.46x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 8.48×.Updated Oct 25, 2026
Gross Margin
36.45%
vs Conglomerates peers
Updated Oct 25, 2026
Profit Margin
2.63%
vs Conglomerates peers
Updated Oct 25, 2026
Operating Margin
5.30%
vs Conglomerates peers
Updated Oct 25, 2026
Return on Assets (TTM)
3.79%
vs Conglomerates peers
Updated Oct 25, 2026
Return on Equity (TTM)
8.58%
vs Conglomerates peers
Updated Oct 25, 2026
Revenue (TTM)
7.65BNOK
793.84M · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
151.08NOKUpdated Oct 25, 2026
Quarterly Revenue Growth
20.60%
vs Conglomerates peers
Updated Oct 25, 2026
Gross Profit (TTM)
2.70BNOK
280.27M · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
821.10MNOK
85.25M · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
201.20MNOK
20.89M · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
49.20%
vs Conglomerates peers
Updated Oct 25, 2026
Operating Cash Flow (TTM)
642.40MNOK
66.69M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
444.49MNOK
46.15M · vs all stocks (USD)
Updated Oct 25, 2026
Forward Annual Dividend Rate
0.8000NOKUpdated Oct 25, 2026
Forward Annual Dividend Yield
0.68%
vs all stocks
Updated Oct 25, 2026
Trailing Annual Dividend Rate
0.8000NOKUpdated Oct 25, 2026
Trailing Annual Dividend Yield
0.68%
vs all stocks
Updated Oct 25, 2026
Payout Ratio
20.36%
vs Conglomerates peers
Updated Oct 25, 2026
Minority Interest (Equity)
3.30MNOKFY2025 · Dec 31, 2025
Revenue
6.42BNOKFY2025 · Dec 31, 2025
Cost of Goods Sold
4.12BNOKFY2025 · Dec 31, 2025
Gross Profit
2.30BNOKFY2025 · Dec 31, 2025
Operating Income
322.10MNOK
33.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
167.30MNOKFY2025 · Dec 31, 2025
Income Tax Expense
32.90MNOKFY2025 · Dec 31, 2025
Net Income
134.40MNOKFY2025 · Dec 31, 2025
EBIT
283.60MNOKFY2025 · Dec 31, 2025
EBITDA (Income Statement)
656.90MNOKFY2025 · Dec 31, 2025
Other Operating Expenses
509.30MNOKFY2025 · Dec 31, 2025
Non-operating Interest Income
10.40MNOKFY2025 · Dec 31, 2025
Non-operating Interest Expense
116.30MNOKFY2025 · Dec 31, 2025
EPS (Basic)
2.80NOKFY2025 · Dec 31, 2025
EPS (Diluted)
2.75NOKFY2025 · Dec 31, 2025
Basic Shares Outstanding
47.90MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
47.90MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
134.40MNOKFY2025 · Dec 31, 2025
Minority Interests (P&L)
-700.00KNOKFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00NOKFY2025 · Dec 31, 2025
Operating Cash Flow
646.60MNOKFY2025 · Dec 31, 2025
Free Cash Flow
601.10MNOKFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.09BNOKFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
137.90MNOKFY2025 · Dec 31, 2025
Other Non-cash Items
508.70MNOKFY2025 · Dec 31, 2025
Capital Expenditures
-45.50MNOKFY2025 · Dec 31, 2025
Net Acquisitions
-278.60MNOKFY2025 · Dec 31, 2025
Sale of Investments
0.00NOKFY2025 · Dec 31, 2025
Other Investing Activity
-300.00KNOKFY2025 · Dec 31, 2025
Net Investing Cash Flow
-324.40MNOKFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.00BNOKFY2025 · Dec 31, 2025
Long-term Debt Payments
-708.30MNOKFY2025 · Dec 31, 2025
Common Stock Repurchase
-26.00MNOKFY2025 · Dec 31, 2025
Other Financing Charges
-200.00KNOKFY2025 · Dec 31, 2025
Net Financing Cash Flow
632.20MNOKFY2025 · Dec 31, 2025
Shares Outstanding
51.21MSharesUpdated Oct 25, 2026
Float Shares
28.51MSharesUpdated Oct 25, 2026
% Held by Insiders
45.05%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
15.64%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
622.30MNOK
64.61M · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
12.13NOKUpdated Oct 25, 2026
Total Debt (MRQ)
1.59BNOK
165.56M · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
0.6485x
vs Conglomerates peers
Updated Oct 25, 2026
Current Ratio (MRQ)
0.9600x
vs Conglomerates peers
Updated Oct 25, 2026
Book Value per Share (MRQ)
47.85NOKUpdated Oct 25, 2026
Total Assets
6.31BNOK
655.43M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.60BNOKFY2025 · Dec 31, 2025
Total Liabilities
3.97BNOKFY2025 · Dec 31, 2025
Total Non-current Assets
3.71BNOKFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.40BNOKFY2025 · Dec 31, 2025
Total Current Liabilities
2.57BNOKFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.26BNOKFY2025 · Dec 31, 2025
Accounts Receivable
909.60MNOKFY2025 · Dec 31, 2025
Inventory
79.80MNOKFY2025 · Dec 31, 2025
Accounts Payable
922.30MNOKFY2025 · Dec 31, 2025
Short-term Debt
311.10MNOKFY2025 · Dec 31, 2025
Other Current Liabilities
132.50MNOKFY2025 · Dec 31, 2025
Long-term Debt
1.25BNOKFY2025 · Dec 31, 2025
Other Non-current Liabilities
4.10MNOKFY2025 · Dec 31, 2025
Common Stock (Book)
25.20MNOKFY2025 · Dec 31, 2025
Retained Earnings
141.80MNOKFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.35BNOK
243.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
200.00KNOKFY2025 · Dec 31, 2025
52-Week Low
81.10NOKUpdated Oct 25, 2026
52-Week High
126.00NOKUpdated Oct 25, 2026
52-Week Change
34.72%
vs all stocks
Updated Oct 25, 2026
Beta
0.3410x
vs all stocks
Updated Oct 25, 2026
50-Day MA
110.90NOKUpdated Oct 25, 2026
200-Day MA
109.68NOKUpdated Oct 25, 2026
Avg 10-Day Volume
141.45KSharesUpdated Oct 25, 2026
Avg 30-Day Volume
191.01KSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
3.96NOKUpdated Oct 25, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.88: grey zoneSignificant
Altman Z-Score: 1.88
High earnings qualityNotable
Earnings Quality Score: 2.89
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $793.84M, above the global median of $566.17MNotable